NTG injection

Ferron Par Pharmaceuticals

Ingredients in every 10 ml

Glyceryl Trinitrate 1 mg

Each package contains

10 ampoules of 10 ml

Other details

Dosage form:Injection
Flavour: None

W.H.O. classification

ATC Level 1: C - Cardiovascular system
ATC Level 2: C01 - Cardiac Therapy Drugs
ATC Level 3: C01E - Other Cardiac Preparations in ATC



CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.


CAUTIONThis item may not be safe for use during lactation. Use with caution.


NOT SAFEThis item should not be used with alcohol.


CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution.

Available in


Dosage information

The recommended dosage range is 10-200 μg/minute but up to 400 μg/minute may be necessary during some surgical procedures.

Glyceryl trinitrate solution is a concentrate which should be diluted prior to IV administration. The product is normally administered IV as an admixture using a suitable vehicle such as 5% dextrose or 0.9% sodium chloride injection

A starting dose of 25 μg/minute is recommended for the control of hypertension, or to produce hypotension during surgery. This may be increased by increments of 25 μg/minute at 5-minute intervals until the blood pressure is stabilized. Doses between 10-200 μg are usually sufficient during surgery, although doses of up to 400 μg/minute have been required in some cases

The recommended starting dose is 20-25 μg/minute. This may be decreased to 10 μg/minute or increased in steps of 20-25 μg/minute every 15-30 minutes until the desired effect is obtained.

An initial dose of 10 μg/minute is recommended, with increments of 10 μg/minute being made at approximately 30 minute intervals according to the needs of the patien


• Surgery:
– The rapid control of hypertension during cardiac surgery. (I p.1, II p.537, III p.1, IV p.1, V p.2178, VI p.1798, VII p.N118, VIII p.1297)
– Reducing blood pressure and maintain controlled hypotension during surgical procedures. (II p.537, III p.1, IV p.1, V p.2178, VI p.1798, VIII p.1297)
– Controlling myocardial ischemia during and after surgery. (II p.537, III p.1, IV p.1)
• Unresponsive congestive heart failure secondary to acute myocardial infarction. (I p.1, II p.537, III p.1, IV p.1, V p.2178, VI p.1798, VII p.N118, VIII p.1297)
• Unstable angina which is refractory to treatment with beta blockers and sublingual nitrates. (I p.1, II p.537, III p.1, IV p.1, V p.2178, VI p.1798, VII p.N118, VIII p.1298)


The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.